2018
DOI: 10.1038/s41598-018-25065-9
|View full text |Cite
|
Sign up to set email alerts
|

Japanese GWAS identifies variants for bust-size, dysmenorrhea, and menstrual fever that are eQTLs for relevant protein-coding or long non-coding RNAs

Abstract: Traits related to primary and secondary sexual characteristics greatly impact females during puberty and day-to-day adult life. Therefore, we performed a GWAS analysis of 11,348 Japanese female volunteers and 22 gynecology-related phenotypic variables, and identified significant associations for bust-size, menstrual pain (dysmenorrhea) severity, and menstrual fever. Bust-size analysis identified significant association signals in CCDC170-ESR1 (rs6557160; P = 1.7 × 10−16) and KCNU1-ZNF703 (rs146992477; P = 6.2 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 99 publications
0
6
0
Order By: Relevance
“…Out of these, we extracted the subset of 25 papers that were both applied papers (rather than methodological) and for which full text could be accessed (S1 Table). The studies covered a variety of trait pairs, generally integrating a disease GWAS with molecular quantitative trait loci (QTL) data, [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] but also comparing pairs of disease GWAS, [40] eQTL and pQTL [41,42] or eQTL and other molecular traits. [43,44] Only four studies considered the potential for multiple causal variants in a region, either discussing the implications on their results, or using conditioning in at least one trait, and 22 out of 25 studies used the software default priors across this diverse range of trait pairs.…”
Section: Resultsmentioning
confidence: 99%
“…Out of these, we extracted the subset of 25 papers that were both applied papers (rather than methodological) and for which full text could be accessed (S1 Table). The studies covered a variety of trait pairs, generally integrating a disease GWAS with molecular quantitative trait loci (QTL) data, [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] but also comparing pairs of disease GWAS, [40] eQTL and pQTL [41,42] or eQTL and other molecular traits. [43,44] Only four studies considered the potential for multiple causal variants in a region, either discussing the implications on their results, or using conditioning in at least one trait, and 22 out of 25 studies used the software default priors across this diverse range of trait pairs.…”
Section: Resultsmentioning
confidence: 99%
“…Disorders at the level of the ESR2 and CYP19A1 gene expressions, observed in endometriosis as related to the types and sites of lesions, associated with the disease, are confirmed by world literature reports [14][15][16][17][18][19][20]. Several different studies are conducted in order to evaluate the risk of endometriosis in association with different genes polymorphism: CYP17A1, CYP19A1, ESR1, ESR2, PGR, HSD17B1, and HSD17B2 [21][22][23][24][25][26].…”
Section: Discussionmentioning
confidence: 90%
“…These SNPs mapped closely to L3MBTL4 which encodes the histone methyl-lysine binding protein and was genome-wide significant in a GWAS of pain severity in dysmenorrhea ( 13 ), a pain syndrome in women characterized by pain with menses.…”
Section: Resultsmentioning
confidence: 99%
“…Based on the findings in the exploratory GWAS, we analyzed the effect size [Standardized Mean Difference (SMD)] of hetero- and homozygous variants of the leading SNP of each of the two GWAS. Since a lead finding has been previously linked to pain in dysmenorrhea ( 13 ) and IBS symptom fluctuation has been linked to the menstrual cycle ( 10 , 14 ), we performed a mediation analysis of estradiol on the change in pain frequency linked to the lead SNP of the GWAS. We applied a full mediation model, tested using the PROCESS implementation ( 15 , 16 ) for IBM SPSS.…”
Section: Methodsmentioning
confidence: 99%